A small Chicago-area company is hoping to do what a pharmaceutical giant couldn't: win FDA approval of a medication to boost flagging sexual desire in older women.
The drug—a form of testosterone called LibiGel that's rubbed into the upper arm—is at least two years away from pharmacy shelves. But Lincolnshire-based BioSante Pharmaceuticals helped sponsor a meeting of sex experts last week, seeking to convince them the company's on the right track.